share_log

This McKesson Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

This McKesson Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

這位麥克森分析師轉爲看好;以下是週四的前五次評級升級
Benzinga ·  11/07 20:56

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

華爾街頂級分析師改變了對這些頂級公司的展望。如需查看包括升級和降級在內的所有分析師評級變化的完整視圖,請參閱我們的分析師評級頁面。

  • Baird analyst Eric Coldwell upgraded the rating for McKesson Corporation (NYSE:MCK) from Neutral to Outperform and raised the price target from $531 to $688. McKesson shares closed at $549.31 on Wednesday. See how other analysts view this stock.
  • Raymond James analyst Ric Prentiss upgraded United States Cellular Corporation (NYSE:USM) from Market Perform to Outperform and announced a price target of $86. United States Cellular shares closed at $65.15 on Wednesday. See how other analysts view this stock.
  • Cantor Fitzgerald analyst Kristen Kluska upgraded the rating for Sarepta Therapeutics, Inc. (NASDAQ:SRPT) from Neutral to Overweight and boosted the price target from $152 to $167. Sarepta Therapeutics shares closed at $127.97 on Wednesday. See how other analysts view this stock.
  • JP Morgan analyst Alexei Gogolev upgraded Clearwater Analytics Holdings, Inc. (NYSE:CWAN) from Neutral to Overweight and raised the price target from $23 to $33. Clearwater Analytics shares closed at $28.58 on Wednesday. See how other analysts view this stock.
  • Wells Fargo analyst Steven Cahall upgraded the rating for Sinclair, Inc. (NASDAQ:SBGI) from Underweight to Equal-Weight and increased the price target from $13 to $19. Sinclair shares closed at $17.41 on Wednesday. See how other analysts view this stock.
  • 貝爾分析師埃裏克·科德威爾將麥克森公司(紐交所:MCK)的評級從中立調升至表現優異,並將目標股價從531美元提高至688美元。麥克森的股價週三收盤價爲549.31美元。看看其他分析師如何看待這支股票。
  • 雷蒙德·詹姆斯的分析師裏克·普林蒂斯將美國無線電話公司(紐交所:USM)的評級從市場表現調升至表現優異,並公佈了86美元的目標股價。美國無線電話的股價週三收盤價爲65.15美元。看看其他分析師如何看待這支股票。
  • 康泰克·菲茨傑拉德的分析師克里斯汀·克盧斯卡將Sarepta Therapeutics公司(納斯達克:SRPT)的評級從中立調升至增持,並將目標股價從152美元提高至167美元。Sarepta Therapeutics的股價週三收盤價爲127.97美元。看看其他分析師如何看待這支股票。
  • 摩根大通的分析師阿列克謝·戈戈列夫將Clearwater Analytics Holdings公司(紐交所:CWAN)的評級從中立調升至增持,並將目標股價從23美元提高至33美元。Clearwater Analytics的股價週三收盤價爲28.58美元。看看其他分析師如何看待這支股票。
  • 富國銀行的分析師史蒂文·卡霍將Sinclair公司(納斯達克:SBGI)的評級從減持調升至持平,並將目標股價從13美元提高至19美元。Sinclair的股價週三收盤價爲17.41美元。看看其他分析師如何看待這支股票。

Considering buying MCK stock? Here's what analysts think:

考慮購買麥克森股票嗎?以下是分析師的建議:

big

Read This Next:

Read This Next:

  • Jim Cramer: This Financial Stock Is A Buy, Likes Broadcom
  • 吉姆·克萊默:這家金融股值得買入,喜歡博通

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論